Hizentra® in Inflammatory Neuropathies - pHeNIx Study

RecruitingOBSERVATIONAL
Enrollment

100

Participants

Timeline

Start Date

June 10, 2022

Primary Completion Date

December 31, 2027

Study Completion Date

December 31, 2027

Conditions
Chronic Inflammatory Demyelinating Polyneuropathy
Interventions
BIOLOGICAL

Hizentra

Solution for injection for subcutaneous use

Trial Locations (27)

26000

RECRUITING

CH de Valence, Valence

35760

RECRUITING

Centre hospitalier privé Saint Grégoire, Rennes

67091

NOT_YET_RECRUITING

CHU de Strasbourg, Strasbourg

80054

NOT_YET_RECRUITING

CHU Amiens Picardie 1, Amiens

86000

RECRUITING

CHU Poitiers, Poitiers

Unknown

RECRUITING

CHU Angers, Angers

RECRUITING

Hôpital privé de La Casamance, Aubagne

RECRUITING

CH Bayonne, Bayonne

RECRUITING

Hôpital Pellegrin, Bordeaux

RECRUITING

CHRU Brest, Brest

RECRUITING

Hôpital Henri Mondor, Créteil

RECRUITING

Hôpital Bicêtre, Le Kremlin-Bicêtre

RECRUITING

CH Libourne, Libourne

RECRUITING

Hôpital Roger Salengro, CHU Lille, Lille

RECRUITING

Hôpital Dupuytren, Limoges

RECRUITING

Hôpital Pierre Wertheimer,HCL, Lyon

RECRUITING

Hôpital de la Timone, Marseille

RECRUITING

CHU Montpellier, Montpellier

RECRUITING

CHRU Nancy, Nancy

RECRUITING

CHU Nantes, Nantes

RECRUITING

Hôpital Pasteur, Nice

RECRUITING

Hôpital Lariboisière, Paris

RECRUITING

La Pitié-Salpêtrière, Paris

RECRUITING

Hôpital Charles Nicolle, Rouen

RECRUITING

CHU Saint-Etienne, Saint-Etienne

NOT_YET_RECRUITING

CHU Toulouse, Toulouse

RECRUITING

CHR Tours, Tours

Sponsors

Lead Sponsor

All Listed Sponsors
lead

CSL Behring

INDUSTRY